Morgan Stanley kept Apple as its "Top Pick" for 2025 as the bank sees the tech giant's artificial intelligence (AI) product ...

Sempra (NYSE:SRE) +1.5% in Friday's trading as Morgan Stanley upgrades to Overweight from Equal Weight with a $98 price ...

Morgan Stanley has upgraded PTC Therapeutics (PTCT), while downgrading Immuneering (IMRX) and Amicus Therapeutics (FOLD).

Sempra (SRE) stock saw a modest uptick, ending the day at $89.16 which represents a slight increase of $1.23 or 1.40% from the prior close of $87.93. The stock opened at $89.01 and touched a low of ...

The stock's fall snapped a two-day winning streak.

Morgan Stanley analyst Alex Straton lowered the firm’s price target on Nike (NKE) to $80 from $82 and keeps an Equal Weight ...

Morgan Stanley's investment management division has agreed to offload its 50% stake in Larus Holding Limited, the 100% owner ...

Morgan Stanley is close to an agreement to buy around €900 million ($940 million) in Spanish mortgages from Banco Santander ...

The bank failed to detect “hundreds” of instances when brokers misappropriated client funds through unauthorized Automated ...

The U.S. Securities and Exchange Commission said that Morgan Stanley failed to detect hundreds of unauthorized transfers that ...

Morgan Stanley Direct Lending Fund offers a 10% dividend yield and a low-risk portfolio. Read why MSDL would be an appealing ...

Morgan Stanley analyst Erik Woodring notes that Apple (AAPL) has outperformed the S&P 500 by 10 points over the last month and shares are ...